• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Compliance (OC) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Data is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20118592
Nov 20118595
Dec 20118595
Jan 20128592
Feb 20128588
Mar 20128594
Apr 20128594
May 20128596
Jun 20128593
Jul 20128593
Aug 20128593
Sep 20128592

FY 2012 Overall: 93%

Number of OC intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A174
Nov 2011N/A228
Dec 2011N/A188
Jan 2012N/A221
Feb 2012N/A249
Mar 2012N/A278
Apr 2012N/A240
May 2012N/A249
Jun 2012N/A289
Jul 2012N/A295
Aug 2012N/A331
Sep 2012N/A183

FY 2012 Total: 2,925

Total number of OC intra- and inter-Office eConsults completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A189
Nov 2011N/A241
Dec 2011N/A198
Jan 2012N/A239
Feb 2012N/A284
Mar 2012N/A295
Apr 2012N/A255
May 2012N/A259
Jun 2012N/A310
Jul 2012N/A317
Aug 2012N/A357
Sep 2012N/A199

FY 2012 Total: 3,143

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.